000 01442 a2200409 4500
005 20250517035709.0
264 0 _c20160310
008 201603s 0 0 eng d
022 _a2162-3279
024 7 _a10.1002/brb3.337
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIzquierdo, Guillermo
245 0 0 _aEffectiveness of glatiramer acetate compared to other multiple sclerosis therapies.
_h[electronic resource]
260 _bBrain and behavior
_cJun 2015
300 _ae00337 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aDisability Evaluation
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aGlatiramer Acetate
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis
_xdiagnosis
650 0 4 _aPatient Outcome Assessment
650 0 4 _aQuality of Life
650 0 4 _aRetrospective Studies
650 0 4 _aSecondary Prevention
_xmethods
650 0 4 _aSpain
_xepidemiology
700 1 _aGarcía-Agua Soler, Nuria
700 1 _aRus, Macarena
700 1 _aGarcía-Ruiz, Antonio José
773 0 _tBrain and behavior
_gvol. 5
_gno. 6
_gp. e00337
856 4 0 _uhttps://doi.org/10.1002/brb3.337
_zAvailable from publisher's website
999 _c24993062
_d24993062